Stronger anticoagulation therapy may be needed for patients with metastatic cancer after bone lesion surgery
the ONA take:
A high risk for venous thromboembolism (VTE) following surgery for long-bone reconstruction was found in patients with metastatic cancer.
These findings from a study by Sidney Kimmel Medical College at Thomas Jefferson University researchers were published in Journal of Bone and Joint Surgery.
The researchers retrospectively reviewed 336 cases in which patients underwent intramedullary nailing for metastatic bone lesions.
Results demonstrated that VTEs developed in 24 patients (7.1%) in the 90 days after surgery, but they also found a low incidence of postoperative wound complications (3.1%).
In addition, 66% of the patients who had developed blood clots also had a primary cancer of the lung. Additional findings were that patients who did not receive radiotherapy after surgery had a slightly lower risk of developing a blood clot.
The researchers conclude that these findings suggest anticoagulation agent, as well as duration of therapy, should be individualized to each patient and their primary cancer. Anticoagulation therapy should also be managed with a team approach that includes the oncologic, medical, radiation, and surgical teams.
A high risk for venous thromboembolism following surgery for long-bone reconstruction was found in patients with metastatic cancer.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Aligning Patient Goals With End of Life Treatment Decisions
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|